Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de estudo
Tipo de documento
Intervalo de ano de publicação
1.
Nucleic Acids Res ; 40(18): 9044-59, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22810208

RESUMO

The structure specific flap endonuclease 1 (FEN1) plays an essential role in long-patch base excision repair (BER) and in DNA replication. We have generated a fluorescently tagged FEN1 expressing mouse which allows monitoring the localization and kinetics of FEN1 in response to DNA damage in living cells and tissues. The expression of FEN1, which is tagged at its C-terminal end with enhanced yellow fluorescent protein (FEN1-YFP), is under control of the endogenous Fen1 transcriptional regulatory elements. In line with its role in processing of Okazaki fragments during DNA replication, we found that FEN1-YFP expression is mainly observed in highly proliferating tissue. Moreover, the FEN1-YFP fusion protein allowed us to investigate repair kinetics in cells challenged with local and global DNA damage. In vivo multi-photon fluorescence microscopy demonstrates rapid localization of FEN1 to local laser-induced DNA damage sites in nuclei, providing evidence of a highly mobile protein that accumulates fast at DNA lesion sites with high turnover rate. Inhibition of poly (ADP-ribose) polymerase 1 (PARP1) disrupts FEN1 accumulation at sites of DNA damage, indicating that PARP1 is required for FEN1 recruitment to DNA repair intermediates in BER.


Assuntos
Reparo do DNA , Endonucleases Flap/metabolismo , Animais , Proteínas de Bactérias/genética , Encéfalo/metabolismo , Células Cultivadas , Dano ao DNA , Endonucleases Flap/análise , Endonucleases Flap/genética , Técnicas de Introdução de Genes , Cinética , Proteínas Luminescentes/genética , Camundongos , Poli(ADP-Ribose) Polimerase-1 , Inibidores de Poli(ADP-Ribose) Polimerases , Antígeno Nuclear de Célula em Proliferação/análise , Fase S
2.
Carcinogenesis ; 32(1): 80-5, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21062970

RESUMO

Oxidative DNA modifications such as 7,8-dihydro-8-oxoguanine (8-oxoG) are generated endogenously in apparently all living cells. The defect of the repair of 8-oxoG in Csb(m/m)Ogg1⁻(/)⁻ mice results in elevated basal levels of these lesions and increased frequencies of spontaneous mutations, which initiate tumorigenesis in the liver if cell proliferation is stimulated. Here, we describe that the phytoalexin resveratrol, applied either for 7 days per gavage (100 mg/kg body wt) or for 3-9 months in the diet (0.04% ad libitum), reduces the endogenous oxidative DNA base damage in the livers of the Csb(m/m)Ogg1⁻(/)⁻ mice by 20-30% (P < 0.01). A small but consistent effect is also observed in the wild-type animals. The spontaneous mutation frequencies determined in the lacI gene of BigBlue® Csb(m/m)Ogg1⁻(/)⁻ mice are concomitantly reduced by resveratrol to similar extents. Mechanistically, the protection is caused by an induction of the antioxidant defense system since (i) hepatocytes isolated from all resveratrol-treated animals were less susceptible to the generation of single-strand breaks and to cell killing by H2O2, (ii) messenger RNA levels of superoxide dismutases 1 and 2 (SOD1 and SOD2) heme oxygenase-1 and glutathione peroxidase were significantly upregulated after the short-term treatment and (iii) mutations primarily ascribed to the oxidative base modification 8-oxoG (G:C to T:A transversions) were more strongly suppressed than G:C to A:T transitions ascribed to spontaneous deamination. The results thus demonstrate that spontaneous somatic mutation rates resulting from endogenous oxidative DNA damage can be reduced by application of an exogenous agent.


Assuntos
Antimutagênicos/administração & dosagem , Fígado/efeitos dos fármacos , Mutagênese/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Estilbenos/administração & dosagem , Animais , Dano ao DNA/efeitos dos fármacos , Dieta , Expressão Gênica/efeitos dos fármacos , Camundongos , Camundongos Transgênicos , Estresse Oxidativo/fisiologia , Resveratrol , Reação em Cadeia da Polimerase Via Transcriptase Reversa
3.
Cancer Res ; 68(12): 4571-9, 2008 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-18559501

RESUMO

Flap endonuclease 1 (FEN1) processes Okazaki fragments in lagging strand DNA synthesis, and FEN1 is involved in several DNA repair pathways. The interaction of FEN1 with the proliferating cell nuclear antigen (PCNA) processivity factor is central to the function of FEN1 in both DNA replication and repair. Here we present two gene-targeted mice with mutations in FEN1. The first mutant mouse carries a single amino acid point mutation in the active site of the nuclease domain of FEN1 (Fen1(E160D/E160D)), and the second mutant mouse contains two amino acid substitutions in the highly conserved PCNA interaction domain of FEN1 (Fen1(DeltaPCNA/DeltaPCNA)). Fen1(E160D/E160D) mice develop a considerably elevated incidence of B-cell lymphomas beginning at 6 months of age, particularly in females. By 16 months of age, more than 90% of the Fen1(E160D/E160D) females have tumors, primarily lymphomas. By contrast, Fen1(DeltaPCNA/DeltaPCNA) mouse embryos show extensive apoptosis in the forebrain and vertebrae area and die around stage E9.5 to E11.5.


Assuntos
Apoptose , Embrião de Mamíferos/metabolismo , Embrião de Mamíferos/patologia , Endonucleases Flap/fisiologia , Linfoma/etiologia , Linfoma/patologia , Antígeno Nuclear de Célula em Proliferação/fisiologia , Animais , Animais Recém-Nascidos , Ciclo Celular/fisiologia , Proliferação de Células , Células Cultivadas , Meios de Cultura Livres de Soro , Reparo do DNA , Replicação do DNA , Embrião de Mamíferos/citologia , Feminino , Genes de Imunoglobulinas/genética , Genes Letais , Resistência à Insulina , Masculino , Camundongos , Camundongos Mutantes , Mutação/genética , Hibridização de Ácido Nucleico , Obesidade/etiologia , Estrutura Terciária de Proteína , Recombinação Genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA